Johns Hopkins Researchers Offer Lessons Learned From Early Covid-19 Patients

"Prediction model” uses data that can help determine if patients’ conditions are likely to worsen.
Johns Hopkins Medicine

Newswise — Using a combination of demographic and clinical data gathered from seven weeks of COVID-19 patient care early in the coronavirus pandemic, Johns Hopkins researchers today published a “prediction model” they say can help other hospitals care for COVID-19 patients — and make important decisions about planning and resource allocations.

Brian Garibaldi, M.D., associate professor of medicine at the Johns Hopkins University School of Medicine, led a team that published in the Annals of Internal Medicine the article that shares important lessons learned in the care of COVID-19 patients between March 4 and April 24, 2020, at five Johns Hopkins hospitals in Maryland and Washington, D.C.

During those 52 days, The Johns Hopkins Hospital, Johns Hopkins Bayview Medical Center, Howard County General Hospital, Suburban Hospital and Sibley Memorial Hospital admitted a combined 827 people age 18 or older — 336 Black, 264 white, 135 Hispanic, 48 Asian, 2 Native American and 42 multiracial — who tested positive for the coronavirus and had symptoms of COVID-19.

From the data those patients generated, the researchers developed a prediction model using a set of risk factors known to be associated with COVID-19 to forecast how likely a patient’s disease is to worsen while being treated in a hospital and at what point in their care that might happen. Among the risk factors researchers considered as part of the model were a patient’s age, body mass index (BMI), lung health and chronic disease, as well as vital signs and the severity of a patient’s COVID-19 symptoms at the time of admission.

The model, called the “COVID Inpatient Risk Calculator (CIRC),” is available online. Garibaldi says the calculator is meant to help hospital physicians and other health care providers assess the risk of a patient’s condition worsening.

“This is some of what we’ve learned in the months since we started seeing patients with COVID-19 at our hospitals,” says Garibaldi. “As we continue to grapple with high numbers of COVID-19 infections across the United States, it’s important to share knowledge with our colleagues at other hospitals.”

Among the highlights of the study was the rapidity with which the disease can progress from mild or moderate to severe, particularly if a patient had all or some of the risk factors associated with the disease. Forty-five of the patients in the study had severe COVID-19 when they were admitted to the hospital. But 120 patients developed severe disease or died within 12 hours of being admitted. Of the 302 patients in the study who developed severe disease or died, the median time of disease progression was 1.1 days.

“Rapid progression of disease following admission [to the hospital] provides a narrow window to intervene,” Garibaldi writes in the article. “Different combinations of risk factors appear to predict severe disease or death, with probabilities ranging from over 90% to as little as 5%.”

For example, using the CIRC, Garibaldi and his colleagues estimate that a 60-year-old white woman with a BMI of 28, no chronic disease and no fever who is hospitalized for COVID-19 has a 10% chance of her disease worsening by day two of her hospital stay. The longer she’s in the hospital, the greater that chance becomes, at 15% after four days and 16% after a week.

Conversely, the researchers considered an 81-year-old Black woman admitted to the hospital with COVID-19. The hypothetical patient has a BMI of 35, diabetes, hypertension and a fever. CIRC forecasts her probability of progressing to severe disease or even death by just the second day of her hospital stay is 89%. That percentage increases to higher than 95% by days four and seven.

By June 24, 694 of the patients in the study had been discharged from the hospital, 131 had died and seven were still hospitalized with severe COVID-19.

“We identified a few readily measurable demographic and clinical factors that, when assessed on admission to the hospital, can predict if someone has a 5% or a 90% risk of developing severe disease or dying from COVID-19,” says Amita Gupta, M.D., professor of medicine at the Johns Hopkins University School of Medicine, who directs the Center for Clinical Global Health Education and is a co-author of the study. “This is incredibly useful information to have when communicating with patients and their families, as well as for informing resource allocation in the hospital.”

The study’s data comes from a registry of all patients treated for the novel coronavirus infection at hospitals in the Johns Hopkins system. Known as “JH-CROWN,” the registry — which is funded by InHealth, the institution’s precision medicine initiative — offers demographics, diagnoses, procedures, social histories and other data points relevant to caring for COVID-19 patients.

“The JH-CROWN data registry embodies the same teamwork and dedication that went into the care of more than 3,000 COVID-19 patients admitted to Johns Hopkins hospitals since the start of the pandemic,” Garibaldi says. “We hope it can teach us more about the nature of COVID-19 and improve both patient care and research as we prepare for a second wave of infections in the fall.”

A co-author of the study, Johns Hopkins University Bloomberg School of Public Health biostatistics professor Scott Zeger, Ph.D, calls JH-CROWN “part of a transformation of Johns Hopkins Medicine into a learning health care system,” where data provides real-time analytics that help doctors, nurses and other health care professionals zero in on precision care for each patient.

In addition to Garibaldi, Zeger and Gupta, the article’s authors are Matthew Robinson, M.D.; Masoud Rouhizadeh, Ph.D.; Jamie Perin, Ph.D.; Grant Schumock, B.S.; Paul Nagy Ph.D.; Josh H. Gray B.S.; Harsha Malapati, B.S.; Mariam Ghobadi-Krueger, B.S.; Timothy M. Niessen, M.D., M.P.H.; Bo Soo Kim, M.D.; Peter M. Hill, M.D.; M. Shafeeq Ahmed, M.D., M.B.A.; Eric D. Dobkin, M.D.; Renee Blanding, M.D.; Jennifer Abele, M.D., M.B.A.; Bonnie Woods, M.S.; Kenneth Harkness, M.S.; David R. Thiemann, M.D.; Mary G. Bowring, M.P.H.; Aalok B. Shah, M.Eng., and Antony Rosen, M.B.Ch.B., M.S., of the Johns Hopkins University School of Medicine and Jacob Fiksel Ph.D.; John Muschelli, Ph.D.; Mei-Cheng Wang, Ph.D., and Karen Bandeen-Roche, Ph.D., of the Johns Hopkins University Bloomberg School of Public Health.

The authors report no conflicts of interest.


Filters close

Showing results

110 of 3765
Released: 23-Oct-2020 4:55 PM EDT
Woman recovering from COVID-19 shares experience as monoclonal antibody clinical trial participant
University of Texas Health Science Center at Houston

When Christina Loville tested positive for the coronavirus, she was terrified. She decided to channel her fear into researching COVID-19 treatments, where she discovered a local clinical trial led by experts at The University of Texas Health Science Center at Houston (UTHealth).

Released: 23-Oct-2020 4:30 PM EDT
"Third spike" in COVID-19 cases, plus the vaccine trials: Live Expert Panel for October 29, 3PM EDT

"Third spike" in COVID-19 cases, plus the vaccine trials: Live Expert Panel for October 29, 3PM EDT

Released: 23-Oct-2020 1:50 PM EDT
Are we really “rounding the corner" when it comes the coronavirus pandemic?

“We’re rounding the turn,” Trump said during the debate. This implies a meaningful improvement. We rate this claim as false. On that very same day the U.S. recorded 77,000 new cases, according to NBC News. This tops the previous high that had been set in July. We may be learning to "live with it," as Trump mentioned, but this is not an improvement.

Newswise: 246719_web.jpg
Released: 23-Oct-2020 12:50 PM EDT
NRL researchers evaluate ultraviolet sources, combat COVID-19
United States Naval Research Laboratory

U.S. Naval Research Laboratory researchers evaluated commercial ultraviolet (UV) sources for viral disinfection to combat COVID-19 on land and at sea, and established a dedicated UV characterization lab in five days to ensure safe introduction and effective operation of UV sources across the Fleet.

Released: 23-Oct-2020 12:05 PM EDT
COVID-19 anxiety linked to body image issues
Anglia Ruskin University

A new study has found that anxiety and stress directly linked to COVID-19 could be causing a number of body image issues amongst women and men.

Newswise: 246747_web.jpg
Released: 23-Oct-2020 11:45 AM EDT
Eliminating COVID-19: What the world can learn from NZ and Taiwan
University of Otago

Both Taiwan and New Zealand have successfully eliminated COVID-19 with world-leading pandemic responses. By taking a particularly proactive approach, Taiwan's response was probably the most effective and least disruptive of any country's, researchers say.

Released: 23-Oct-2020 11:00 AM EDT
Healthcare's earthquake: Lessons from COVID-19
Beth Israel Deaconess Medical Center

The COVID-19 pandemic has fundamentally disrupted U.S. healthcare organizations.

Released: 23-Oct-2020 10:50 AM EDT
COVID-19 lockdown reduced mental health, sleep, exercise
Pennington Biomedical Research Center

A first-of-its-kind global survey shows the initial phase of the COVID-19 lockdown dramatically altered our personal habits, largely for the worse.

Released: 23-Oct-2020 10:45 AM EDT
New Data on Increasing Cloth Mask Effectiveness
Society for Risk Analysis (SRA)

A new study published in Risk Analysis, “Reinventing cloth masks in the face of pandemics,” by Stephen Salter, P.Eng., describes how Effective Fiber Mask Programs (EFMPs) can help communities find a balance between the economy and curbing community spread.

Showing results

110 of 3765